TSMC's October Sales Report Ignites AI Spending Concerns, OpenAI Seeks CHIPS Act Tax Credits
The Rundown
00:00
Analysts Question Pfizer's Price
Zaid shares analysts' view that Pfizer may have overpaid, potentially benefiting Novo Nordisk indirectly.
Play episode from 07:27
Transcript
